Will High-Risk smokers keep up with lung scans? french study aims to find out

NCT ID NCT06020443

Ongoing Knowledge-focused Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tracks 126 heavy smokers aged 50 to 74 in France to see how many complete a three-year lung cancer screening program using low-dose CT scans. Researchers also measure how many people quit smoking during the program. The goal is to understand real-world adherence, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: low-dose chest CT scan
What this could lead to: If successful, this could show how to improve participation in lung cancer screening programs, potentially catching more cancers early.
What could go wrong: This is an observational study, not testing a new treatment. It only measures adherence, so it won't directly prevent or cure lung cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH-RISK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIGH-RISK CANCER LUNG CANCER

Contacts and locations

Locations

Cabinet de médecine générale

Colmar, Haut-Rhin, 68000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.